Software stocks underperformed the broader tech sector for a second straight year in 2025 as concerns about AI disruption ...

Investing.com -- Outlook Therapeutics (NASDAQ:OTLK) stock plummeted 67.7% in after-hours trading Wednesday after the company announced that U.S. regulators rejected its application for a bevacizumab ...

A Delhi-based doctor was duped of Rs 22.7 lakh in what appeared to be a lucrative stock market investment opportunity—only ...

That morning, Vera announced that its biologics license application (BLA) for its atacicept was accepted for priority review ...

Aquestive Therapeutics (NASDAQ:AQST) stock fell 40% on Friday after the company disclosed that the U.S. Food and Drug Administration (FDA) has identified deficiencies in its New Drug Application (NDA) ...

Equity Residential stands out as an attractive, lower-risk income opportunity at today’s price, with it trading near the ...

The bail application of Victor Majola, who is accused of murdering Warrick Stock, popularly known as DJ Warras, has been ...

Outlook Therapeutics' stock fell to a new low due to FDA rejection of its Lytenava filing for wet AMD. Efficacy evidence ...

In an exchange filing on Tuesday, Dharan Infra-EPC said that the suspended board of directors of the company has preferred an ...

The FDA declined to approve EBVALLO (tabelecleucel), Atara’s treatment for Epstein-Barr virus positive post-transplant ...

Information technology index was the second-best-performing sector in 2025, as it rose +25% YTD, while its accompanying State Street Technology Select Sector SPDR ETF (XLK) is +26.14%. As we look at ...

Bharat Coking Coal is selling its shares in the price band of Rs 21-23 apiece, applied for a minimum of 600 shares and its ...